Vireo Growth Inc. (VREOF) stock
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $443.48MP/E –Yield –
Vireo Growth total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Vireo Growth's total debt was $58.21M at Mar 31, 2023. For fiscal 2022 it was $58.03M, up 112.3% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $58.03M | +112.3% |
| FY2021 | Dec 31, 2021 | $27.33M | +2362.2% |
| FY2020 | Dec 31, 2020 | $1.11M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2023 | Mar 31, 2023 | $58.21M | +86.5% |
| Q4 FY2022 | Dec 31, 2022 | $58.03M | +112.3% |
| Q3 FY2022 | Sep 30, 2022 | $55.63M | +171.1% |
| Q2 FY2022 | Jun 30, 2022 | $45.85M | +133.4% |
| Q1 FY2022 | Mar 31, 2022 | $31.21M | +66.4% |
| Q4 FY2021 | Dec 31, 2021 | $27.33M | +2362.2% |
| Q3 FY2021 | Sep 30, 2021 | $20.52M | – |
| Q2 FY2021 | Jun 30, 2021 | $19.64M | – |
| Q1 FY2021 | Mar 31, 2021 | $18.76M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.11M | – |
See a number that looks wrong?